211 related articles for article (PubMed ID: 21741353)
1. Mutations of human cytochrome P450 reductase differentially modulate heme oxygenase-1 activity and oligomerization.
Marohnic CC; Huber Iii WJ; Patrick Connick J; Reed JR; McCammon K; Panda SP; Martásek P; Backes WL; Masters BS
Arch Biochem Biophys; 2011 Sep; 513(1):42-50. PubMed ID: 21741353
[TBL] [Abstract][Full Text] [Related]
2. Diminished FAD binding in the Y459H and V492E Antley-Bixler syndrome mutants of human cytochrome P450 reductase.
Marohnic CC; Panda SP; Martásek P; Masters BS
J Biol Chem; 2006 Nov; 281(47):35975-82. PubMed ID: 16998238
[TBL] [Abstract][Full Text] [Related]
3. Altered heme catabolism by heme oxygenase-1 caused by mutations in human NADPH cytochrome P450 reductase.
Pandey AV; Flück CE; Mullis PE
Biochem Biophys Res Commun; 2010 Sep; 400(3):374-8. PubMed ID: 20732302
[TBL] [Abstract][Full Text] [Related]
4. Human cytochrome P450 oxidoreductase deficiency caused by the Y181D mutation: molecular consequences and rescue of defect.
Marohnic CC; Panda SP; McCammon K; Rueff J; Masters BS; Kranendonk M
Drug Metab Dispos; 2010 Feb; 38(2):332-40. PubMed ID: 19884324
[TBL] [Abstract][Full Text] [Related]
5. Clinical, structural and functional implications of mutations and polymorphisms in human NADPH P450 oxidoreductase.
Flück CE; Nicolo C; Pandey AV
Fundam Clin Pharmacol; 2007 Aug; 21(4):399-410. PubMed ID: 17635179
[TBL] [Abstract][Full Text] [Related]
6. Altered human CYP3A4 activity caused by Antley-Bixler syndrome-related variants of NADPH-cytochrome P450 oxidoreductase measured in a robust in vitro system.
Moutinho D; Marohnic CC; Panda SP; Rueff J; Masters BS; Kranendonk M
Drug Metab Dispos; 2012 Apr; 40(4):754-60. PubMed ID: 22252407
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of a NADPH-cytochrome P450 oxidoreductase (CYPOR) and heme oxygenase 1 fusion protein implies a conformational change in CYPOR upon NADPH/NADP
Sugishima M; Sato H; Wada K; Yamamoto K
FEBS Lett; 2019 Apr; 593(8):868-875. PubMed ID: 30883732
[TBL] [Abstract][Full Text] [Related]
8. Impairment of human CYP1A2-mediated xenobiotic metabolism by Antley-Bixler syndrome variants of cytochrome P450 oxidoreductase.
Kranendonk M; Marohnic CC; Panda SP; Duarte MP; Oliveira JS; Masters BS; Rueff J
Arch Biochem Biophys; 2008 Jul; 475(2):93-9. PubMed ID: 18455494
[TBL] [Abstract][Full Text] [Related]
9. Human heme oxygenase-1 efficiently catabolizes heme in the absence of biliverdin reductase.
Reed JR; Huber WJ; Backes WL
Drug Metab Dispos; 2010 Nov; 38(11):2060-6. PubMed ID: 20679134
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for human NADPH-cytochrome P450 oxidoreductase deficiency.
Xia C; Panda SP; Marohnic CC; Martásek P; Masters BS; Kim JJ
Proc Natl Acad Sci U S A; 2011 Aug; 108(33):13486-91. PubMed ID: 21808038
[TBL] [Abstract][Full Text] [Related]
11. The reactions of heme- and verdoheme-heme oxygenase-1 complexes with FMN-depleted NADPH-cytochrome P450 reductase. Electrons required for verdoheme oxidation can be transferred through a pathway not involving FMN.
Higashimoto Y; Sato H; Sakamoto H; Takahashi K; Palmer G; Noguchi M
J Biol Chem; 2006 Oct; 281(42):31659-67. PubMed ID: 16928691
[TBL] [Abstract][Full Text] [Related]
12. Structural and Kinetic Studies of Asp632 Mutants and Fully Reduced NADPH-Cytochrome P450 Oxidoreductase Define the Role of Asp632 Loop Dynamics in the Control of NADPH Binding and Hydride Transfer.
Xia C; Rwere F; Im S; Shen AL; Waskell L; Kim JP
Biochemistry; 2018 Feb; 57(6):945-962. PubMed ID: 29308883
[TBL] [Abstract][Full Text] [Related]
13. Chimeric enzymes of cytochrome P450 oxidoreductase and neuronal nitric-oxide synthase reductase domain reveal structural and functional differences.
Roman LJ; McLain J; Masters BS
J Biol Chem; 2003 Jul; 278(28):25700-7. PubMed ID: 12730215
[TBL] [Abstract][Full Text] [Related]
14. Electron transfer by human wild-type and A287P mutant P450 oxidoreductase assessed by transient kinetics: functional basis of P450 oxidoreductase deficiency.
Jin Y; Chen M; Penning TM; Miller WL
Biochem J; 2015 May; 468(1):25-31. PubMed ID: 25728647
[TBL] [Abstract][Full Text] [Related]
15. Protein/protein interactions in the mammalian heme degradation pathway: heme oxygenase-2, cytochrome P450 reductase, and biliverdin reductase.
Spencer AL; Bagai I; Becker DF; Zuiderweg ER; Ragsdale SW
J Biol Chem; 2014 Oct; 289(43):29836-58. PubMed ID: 25196843
[TBL] [Abstract][Full Text] [Related]
16. Conformational changes of NADPH-cytochrome P450 oxidoreductase are essential for catalysis and cofactor binding.
Xia C; Hamdane D; Shen AL; Choi V; Kasper CB; Pearl NM; Zhang H; Im SC; Waskell L; Kim JJ
J Biol Chem; 2011 May; 286(18):16246-60. PubMed ID: 21345800
[TBL] [Abstract][Full Text] [Related]
17. Recruitment of governing elements for electron transfer in the nitric oxide synthase family.
Jáchymová M; Martásek P; Panda S; Roman LJ; Panda M; Shea TM; Ishimura Y; Kim JJ; Masters BS
Proc Natl Acad Sci U S A; 2005 Nov; 102(44):15833-8. PubMed ID: 16249336
[TBL] [Abstract][Full Text] [Related]
18. Regulation of gap junction function and Connexin 43 expression by cytochrome P450 oxidoreductase (CYPOR).
Polusani SR; Kar R; Riquelme MA; Masters BS; Panda SP
Biochem Biophys Res Commun; 2011 Aug; 411(3):490-5. PubMed ID: 21726529
[TBL] [Abstract][Full Text] [Related]
19. Structure and function of an NADPH-cytochrome P450 oxidoreductase in an open conformation capable of reducing cytochrome P450.
Hamdane D; Xia C; Im SC; Zhang H; Kim JJ; Waskell L
J Biol Chem; 2009 Apr; 284(17):11374-84. PubMed ID: 19171935
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for the electron transfer from an open form of NADPH-cytochrome P450 oxidoreductase to heme oxygenase.
Sugishima M; Sato H; Higashimoto Y; Harada J; Wada K; Fukuyama K; Noguchi M
Proc Natl Acad Sci U S A; 2014 Feb; 111(7):2524-9. PubMed ID: 24550278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]